WBDE(SZ:002082)2018-04-24 16:00Financial Performance - Revenue for Q1 2018 was CNY 2,712,347,424.22, a slight increase of 0.04% compared to CNY 2,711,223,638.20 in the same period last year[8] - Net profit attributable to shareholders increased by 23.35% to CNY 9,230,292.24 from CNY 7,483,204.13 year-on-year[8] - Net profit excluding non-recurring items rose by 77.05% to CNY 9,714,149.79 compared to CNY 5,486,578.00 in the previous year[8] - Basic earnings per share increased by 33.33% to CNY 0.04 from CNY 0.03 in the same period last year[8] - The net profit attributable to shareholders for the first half of 2018 is expected to range from 29.73 million to 44.595 million RMB, representing a growth of 0.00% to 50.00% compared to the same period in 2017[24] - The stable development of the aluminum segment and the consolidation of Wanbond Medical Technology Co., Ltd. are contributing to the company's profitability[24] Cash Flow and Assets - The net cash flow from operating activities improved by 27.27%, reaching -CNY 45,546,778.19 compared to -CNY 62,625,489.75 in the previous year[8] - Cash and cash equivalents decreased by 34.93% compared to the beginning of the period, mainly due to significant payments for equity transfer and goods[16] - Net cash flow from investing activities decreased by 71.28% year-on-year, primarily due to reduced cash payments for investments[16] - Net cash flow from financing activities increased by 100%, with a net cash inflow of 5.5692 million yuan from new financing activities during the reporting period[16] - Total assets at the end of the reporting period were CNY 2,046,812,440.52, a decrease of 2.54% from CNY 2,100,060,057.08 at the end of the previous year[8] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 30,471[12] - The largest shareholder, Wanbond Group Co., Ltd., held 18.88% of the shares, amounting to 44,943,360 shares, which are pledged[12] - Net assets attributable to shareholders increased by 0.64% to CNY 1,430,558,715.29 from CNY 1,421,513,232.82 at the end of the previous year[8] - The weighted average return on equity was 0.65%, up from 0.54% in the previous year[8] Expenses and Liabilities - Accounts receivable increased by 61.60% compared to the beginning of the period, primarily due to the consolidation of Wanbond Medical Technology Co., Ltd.[16] - Prepayments increased by 287.42% compared to the beginning of the period, attributed to increased prepayment purchases[16] - Other receivables increased by 160.19% compared to the beginning of the period, mainly due to the consolidation of Wanbond Medical Technology Co., Ltd.[16] - Sales expenses increased by 139.06% year-on-year, primarily due to the consolidation of Wanbond Medical Technology Co., Ltd.[16] - Management expenses increased by 172.73% year-on-year, mainly due to the consolidation of Wanbond Medical Technology Co., Ltd.[16] - Financial expenses increased by 560.69% year-on-year, primarily due to the consolidation of Wanbond Medical Technology Co., Ltd. and increased discounting of notes in the aluminum sector[16] - Income tax expenses increased by 87.85% year-on-year, mainly due to increased profits during the reporting period[16] Compliance and Governance - The company has no violations regarding external guarantees during the reporting period[25] - There are no non-operating fund occupations by controlling shareholders or their related parties during the reporting period[26] - The company has not conducted any research, communication, or interview activities during the reporting period[28]